Axel Metzger

Person

East Windsor, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Sting agonists for treating bladder cancer and solid tumors
- Patent number 11,883,420
- Issue date Jan 30, 2024
- Venenum Biodesign, LLC
- Brian F. McGuinness
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sting agonists
- Patent number 11,161,864
- Issue date Nov 2, 2021
- Venenum Biodesign, LLC
- David J. Diller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sting agonists for treating bladder cancer and solid tumors
- Patent number 11,110,106
- Issue date Sep 7, 2021
- Venenum Biodesign, LLC
- Brian F. McGuinness
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Melanocortin receptor-specific spiro-piperidine compounds
- Patent number 8,263,608
- Issue date Sep 11, 2012
- Palatin Technologies, Inc.
- Yi-Qun Shi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-heterocyclic inhibitors of TNF-alpha expression
- Patent number 8,044,040
- Issue date Oct 25, 2011
- Bristol-Myers Squibb Company
- Gulzar Ahmed
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders
- Patent number 7,951,803
- Issue date May 31, 2011
- Pharmacopeia, LLC
- Andrew G. Cole
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-heterocyclic inhibitors of TNF-α expression
- Patent number 7,479,495
- Issue date Jan 20, 2009
- Pharmacopeia, Inc.
- Kevin Joseph Moriarty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-heterocyclic inhibitors of TNF-α expression
- Patent number 7,253,174
- Issue date Aug 7, 2007
- Bristol-Myers Squibb Company
- Gulzar Ahmed
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-heterocyclic inhibitors of TNF-α expression
- Patent number 6,906,067
- Issue date Jun 14, 2005
- Bristol-Myers Squibb Company
- Kevin Joseph Moriarty
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Diamine-Linked Melanocortin Receptor-Specific Cyclic Peptides for O...
- Publication number 20230040236
- Publication date Feb 9, 2023
- Palatin Technologies, Inc.
- Wei YANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Orally Active Melanocortin Receptor-4 Compounds
- Publication number 20220204450
- Publication date Jun 30, 2022
- Palatin Technologies, Inc.
- James Bullington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL STING AGONISTS
- Publication number 20220048936
- Publication date Feb 17, 2022
- Venenum Biodesign, LLC
- David J. Diller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STING AGONISTS FOR TREATING BLADDER CANCER AND SOLID TUMORS
- Publication number 20210290645
- Publication date Sep 23, 2021
- Venenum Biodesign, LLC
- Brian F. McGUINNESS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Orally Active Melanocortin Receptor-4 Compounds
- Publication number 20210198201
- Publication date Jul 1, 2021
- Palatin Technologies, Inc.
- James Bullington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL STING AGONISTS
- Publication number 20200131209
- Publication date Apr 30, 2020
- Venenum Biodesign, LLC
- David J. Diller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS
- Publication number 20110230480
- Publication date Sep 22, 2011
- Andrew G. Cole
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Melanocortin Receptor-Specific Spiro-Piperidine Compounds
- Publication number 20110178080
- Publication date Jul 21, 2011
- Palatin Technologies, Inc.
- Yi-Qun Shi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Purinone derivatives for treating neurodegenerative diseases
- Publication number 20090023723
- Publication date Jan 22, 2009
- Pharmacopeia Drug Discovery, Inc.
- Andrew G. Cole
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted 2-aminothiazoles for treating neurodegenerative diseases
- Publication number 20090005568
- Publication date Jan 1, 2009
- Pharmacopeia Drug Discovery, Inc.
- Andrew G. Cole
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS
- Publication number 20080032971
- Publication date Feb 7, 2008
- Pharmacopeia Drug Discovery, Inc.
- Andrew G. Cole
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-HETEROCYCLIC INHIBITORS OF TNF-ALPHA EXPRESSION
- Publication number 20080015185
- Publication date Jan 17, 2008
- Bristol -Myers Squibb Company
- Gulzar Ahmed
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-heterocyclic inhibitors of TNF-alpha expression
- Publication number 20060276488
- Publication date Dec 7, 2006
- Bristol -Myers Squibb Company
- Gulzar Ahmed
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-heterocyclic inhibitors of TNF-alpha expression
- Publication number 20050239770
- Publication date Oct 27, 2005
- Kevin Joseph Moriarty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-heterocyclic inhibitors of TNF-alpha expression
- Publication number 20030139435
- Publication date Jul 24, 2003
- Gulzar Ahmed
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N- heterocyclic inhibitors of TNF-alpha expression
- Publication number 20020137747
- Publication date Sep 26, 2002
- Kevin Joseph Moriarty
- C07 - ORGANIC CHEMISTRY

Axel Metzger

Person

Patents Grantslast 30 patents

Sting agonists for treating bladder cancer and solid tumors

Sting agonists

Sting agonists for treating bladder cancer and solid tumors

Melanocortin receptor-specific spiro-piperidine compounds

N-heterocyclic inhibitors of TNF-alpha expression

8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders

N-heterocyclic inhibitors of TNF-α expression

N-heterocyclic inhibitors of TNF-α expression

N-heterocyclic inhibitors of TNF-α expression

Patents Applicationslast 30 patents

Diamine-Linked Melanocortin Receptor-Specific Cyclic Peptides for O...

Orally Active Melanocortin Receptor-4 Compounds

NOVEL STING AGONISTS

STING AGONISTS FOR TREATING BLADDER CANCER AND SOLID TUMORS

Orally Active Melanocortin Receptor-4 Compounds

NOVEL STING AGONISTS

8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS

Melanocortin Receptor-Specific Spiro-Piperidine Compounds

Purinone derivatives for treating neurodegenerative diseases

Substituted 2-aminothiazoles for treating neurodegenerative diseases

8-HETEROARYLPURINE MNK2 INHIBITORS FOR TREATING METABOLIC DISORDERS

N-HETEROCYCLIC INHIBITORS OF TNF-ALPHA EXPRESSION

N-heterocyclic inhibitors of TNF-alpha expression

N-heterocyclic inhibitors of TNF-alpha expression

N-heterocyclic inhibitors of TNF-alpha expression

N- heterocyclic inhibitors of TNF-alpha expression